Please use this identifier to cite or link to this item:
|Title:||Therapy-induced drug resistance in a human leukemia line (LALW-2). A clinically relevant model||Authors:||Tiley, Campbell ;White, L.;Haber, M.;Brian, M.J.;Norris, M.D.;Trickett, A.;Sosula, L.;Stewart, B.W.||Issue Date:||Jun-1989||Source:||Volume 63, Issue 11, pp. 2103 - 2010||Journal title:||Cancer||Abstract:||A human leukemic T-cell line, LALW-2, established by xenografting in nude mice, has been maintained through 14 serial passages. The cells display consistent morphologic features, immunophenotype, and karyotypic aberrations (including an 11;14 translocation) and exhibit rearrangement of the T-cell receptor beta-chain gene. The growth rate of LALW-2 xenografts was differentially affected by drugs administered to host mice, the cells being resistant to cytotoxic agents (particularly methotrexate and doxorubicin) used in treatment of the donor patient. In short-term in vitro culture, LALW-2 cells exhibited extreme resistance to methotrexate and were also resistant to vincristine, vinblastine, dactinomycin, and doxorubicin. The findings differ from those obtained with laboratory-derived methotrexate or multidrug-resistant cell lines. The response of LALW-2 cells, in both the nude mouse model and in vitro, is consistent with acquisition of drug-resistance as a result of clinical treatment.||URI:||https://elibrary.cclhd.health.nsw.gov.au/cclhdjspui/handle/1/1684||Pubmed:||https://www.ncbi.nlm.nih.gov/pubmed/2720561||ISSN:||0008-543x||Publicaton type:||Journal Article||Keywords:||Leukaemia
|Appears in Collections:||Oncology / Cancer|
Show full item record
checked on Jan 27, 2023
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.